Bayer: Science For A Better Life

Bayer HealthCare:
Improving the quality of life for people with
multiple sclerosis

Despite major progress in medicine, there are still many conditions that cannot be cured. Multiple sclerosis (MS) is one of them. There used to be no way to mitigate the effects of this nervous system disease, which commonly alternates between flare-ups and symptom-free periods. Things are different now, due in large measure to the arrival of Betaferon®/Betaseron®, an innovative drug from Bayer HealthCare. This was the first drug to reduce the frequency of MS episodes, thus improving patients’ quality of life. Now the results of a new study show that early treatment can further delay the onset of disability.

The refinement of established products capable of enhancing patients’ quality of life is one major focus at Bayer HealthCare. Another is the discovery of new active substances that form milestones along the road to improving the health of people and animals worldwide.

Bayer HealthCare: Improving the quality of life for people with multiple sclerosis

Bayer HealthCare:
Improving the quality of life for people with
multiple sclerosis